Proteolytic and cellular death mechanisms in ovulatory ovarian rupture

NeuroSignals

Volumn 9, Issue 2, 2000, Pages 102-114

  Murdoch, William J ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Apoptosis; Collagenase; Ovulation; Plasmin; Tumor necrosis factor ; Urokinase

Indexed keywords

COLLAGENASE; DNA; GONADOTROPIN; METALLOPROTEINASE; PLASMIN; PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ANIMAL EXPERIMENT; APOPTOSIS; CELL STIMULATION; COLLAGEN DEGRADATION; GENE EXPRESSION; NONHUMAN; OVARY; OVARY CANCER; OVARY DISEASE; OVULATION; PROTEIN DEGRADATION; PROTEIN SECRETION; REVIEW;

ANIMALS; CELL DEATH; FEMALE; HUMANS; OVARY; OVULATION; PEPTIDE HYDROLASES;

OVIS;

EID: 0034119606     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000014629     Document Type: Article

References (125)

1. Espey LL, Lipner H: Ovulation; in Knobil E, Neill JD (eds): The Physiology of Reproduction. New York, Raven Press, 1994, pp 725-780.
2. Karsch FJ, Moenter SM, Caraty A: The neuroendocrine signal for ovulation. Anim Reprod Sci 1992;28: 329-341.
3. Fauser BCJM, Van Heusden AM: Manipulation of human ovarian function: Physiological concepts and clinical consequences. Endocr Rev 1997;18:71-106.
4. Espey LL: Ovulation as an inflammatory reaction-a hypothesis. Biol Reprod 1980;22:73-106.
5. Reich R, Tsafriri A, Mechanic GL: The involvement of collagenolysis in ovulation in the rat. Endocrinology 1985;116:522-527.
6. Murdoch WJ, Peterson TA, Van Kirk EA, Vincent DL, Inskeep EK: Interactive roles of progesterone, prostaglandins, and collagenase in the ovulatory mechanism of the ewe Biol Reprod 1986;35:1187-1194.
7. Woessner JF, Morioka N, Zhu C, Mukaida T, Butler T, LeMaire WJ: Connective tissue breakdown in ovulation. Steroids 1989;54:491-499.
8. Murdoch WJ: Ovarian surface epithelium during ovulatory and anovulatory ovine estrous cycles. Anat Rec 1994;240:322-326.
9. Murdoch WJ: Programmed cell death in preovulatory ovine follicles. Biol Reprod 1995;53:8-12.
10. Murdoch WJ: Endothelial cell death in preovulatory ovine follicles: Possible implication in the biomechanics of rupture. J Reprod Fertil 1995; 105:161-164.
11. Murdoch WJ, Colgin DC, Ellis JA: Role of tumor necrosis factor-a in the ovulatory mechanism of ewes. J Anim Sci 1997;75:1601-1605.
12. Anderson E, Lee G, Letourneau R, Albertini DF, Meller SM: Cytologi-cal observations of the ovarian epithelium in mammals during the reproductive cycle. J Morphol 1976; 150:135-166.
13. Mossman HW, Duke KL: Comparative Morphology of the Mammalian Ovary. Madison, University of Wisconsin Press, 1973.
14. Bjersing L, Cajander S: Ovulation and the role of the ovarian surface epithelium. Experientia 1975;31: 605-608.
15. Colgin DC, Murdoch WJ: Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: Secretion of urokinase-type plasminogen activator. Anim Reprod Sci 1997;47:197-204.
16. Dano K, Andreasen PA, Grandahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44:139-266.
17. Murdoch WJ, Van Kirk EA, Murdoch J: Plasmin cleaves tumor necrosis factor a exodomain from sheep follicular endothelium: Implication in the ovulatory process. Biol Reprod 1999;60:1166-1171.
18. Johnson ML, Murdoch J, Van Kirk EA, Kaltenbach JE, Murdoch WJ: Tumor necrosis factor a regulates collagenolytic activity in preovulatory ovine follicles: Relationship to cytokine secretion by the oocyte-cumulus cell complex. Biol Reprod 1999;61:1581-1585.
19. Murdoch WJ, Lund SA: Prostaglandin-independent anovulatory mechanism of indomethacin action: Inhibition of tumor necrosis factor • induced sheep ovarian cell apoptosis. Biol Reprod 1999;61: 1655-1659.
20. Ackerman RC, Murdoch WJ: Prostaglandin-induced apoptosis of ovarian surface epithelial cells. Prostaglandins 1993;45:475-485.
21. Murdoch WJ: Perturbation of sheep ovarian surface epithelial cells by ovulation: Evidence for roles of progesterone and poly(ADP-ribose) polymerase in the restoration of DNA integrity. J Endocrinol 1998; 156:503-508.
22. Murdoch WJ: Ovarian surface epithelium, ovulation, and carcinogenesis. Biol Rev 1996;71:529-543.
23. Berchuck A, Carney M: Human ovarian cancer of the surface epithelium. Biochem Pharmacol 1997;54: 541-544.
24. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC: The biology of ovarian cancer. Semin Oncol 1998;25:281-304.
25. Roberts AJ, Dunn TG, Murdoch WJ: Induction of ovulation in proes-trous ewes: Identification of the ovulatory follicle and functional status of the corpus luteum. Domest Anim Endocrinol 1985;2:207-210.
26. Murdoch WJ: Follicular determinants of ovulation in the ewe. Domest Anim Endocrinol 1985;2:105-121.
27. Hart DA, Rehemtulla A: Plasminogen activators and their inhibitors: Regulators of extracellular proteolysis and cell function. Comp Bio-chem Physiol 1988;90B:691-708.
28. Tsafriri A, Reich R: Plasminogen activators in the preovulatory follicle: Role in ovulation; in Abbate R, Barni T, Tsafriri A (eds): Plasminogen Activators: From Cloning to Therapy. New York, Raven Press, 1991, pp 81-93.
29. Carmeleit P, Schoonjans L, Kieck-ens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC: Physiological consequences of loss of plasminogen activator function in mice. Nature 1994;368:419-424.
30. Leonardsson G, Peng X-R, Liu K, Nordstrom L, Carmeliet P, Mulligan R, Collen D, Ny T: Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: Functional redundancy among physiological plasminogen activators. Proc Natl Acad Sci USA 1995;92:12446-12450.
31. Hagglund A-C, Ny A, Liu K, Ny T: Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation. Endocrinology 1996;137:5671-5677.
32. Murdoch WJ: Regulation of collage-nolysis and cell death by plasmin within the formative stigma of preovulatory ovine follicles. J Reprod Fertil 1998;113:331-336.
33. Smokovitis A, Kokolis N, Alexaki-Tzivanidou E: The plasminogen activator activity is markedly increased mainly at the area of the rupture of the follicular wall at the time of ovulation. Anim Reprod Sci 1988;16:285-294.
34. Peng X-R, Hsueh AJW, Ny T; Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation. Eur J Bio-chem 1993;214:147-156.
35. Murdoch J, Van Kirk EA, Murdoch WJ: Hormonal control of urokinase plasminogen activator secretion by sheep ovarian surface epithelial cells. Biol Reprod 1999;61: 1487-1491.
36. Halterman SD, Murdoch WJ: Ovarian function in ewes treated with antihistamines. Endocrinology 1986;119:2417-2421.
37. Cavender JL, Murdoch WJ: Morphological studies of the microcirculatory system of ovulatory ovine follicles. Biol Reprod 1988;39:989-997.
38. Vilcek J, Lee TH: Tumor necrosis factor. J Biol Chem 1991;266:7313-7316.
39. Vandenabeele P, Declercq W, Beyaert R, Fiers W: Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 1995; 5:392-399.
40. Terranova PF: Potential roles of tumor necrosis factor-a in follicular development, ovulation, and the life span of the corpus luteum. Domest Anim Endocrinol 1997; 14:1-15.
41. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP: A metalloproteinase disintegrin that releases tumour necrosis factor-a from cells. Nature 1997;385:729-733.
42. Scuderi P: Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor _p-toluenesulfonyl-L-arginine methyl ester. J Immunol 1989; 143: 168-173.
43. Perona JJ, Craik CS: Structural specificity in the serine proteases. Protein Sci 1995;4:337-360.
44. Zolti M, Meirom R, Shemesh M, Wollach D, Mashiach S, Shore L, Ben-Rafael Z: Granulosa cells as a source and target organ for tumor necrosis factor-a. FEBS Lett 1990; 261:253-255.
45. Brannstrom M, Norman RJ, Seamark RF, Robertson SA: Rat ovary produces cytokines during ovulation. Biol Reprod 1994;50:88-94.
46. deMola JRL, Goldfarb JM, Hecht BR, Baumgardner GP, Babbo CJ, Friedlander MA: Gonadotropins induce the release of interleukin-1 p, interleukin-6 and tumor necrosis factor-a from the human preovulatory follicle. Am J Reprod Immunol 1998;39:387-390.
47. Montgomery-Rice V, Limback SD, Roby KF, Terranova PF: Changes in circulating and ovarian concentrations of bioactive tumour necrosis factor a during the first ovulation at puberty in rats and in gonadotrophin-treated immature rats. J Re-prod Fertil 1998;113:337-341.
48. Bazzoni F, Beutler B: How do tumor necrosis factor receptors work? J In-flamm 1995;45:221-238.
49. Baker T, Reddy E: Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996;12:1-9.
50. Zhivotovsky B, Burgess DH, Orre-nius S: Proteases and apoptosis. Ex-perientia 1996;52:968-978.
51. Boldin MP, Goncharov TM, Golt-sev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-in-teracting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 1996;85:803-815.
52. Muzio M, Chinnaiyan AM, Kisch-kel FC, O’Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM: FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85: 817-827.
53. Alnemri ES: Mammalian cell death proteases: A family of highly conserved asparate specific cysteine proteases. J Cell Biochem 1997;64: 33-42.
54. Dayer JM, Beutler B, Cerami A: Ca-chectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-2168.
55. Mitchell PG, Cheung HS: Protein kinase regulation of tumor necrosis factor a stimulated collagenase and stromelysin message levels in chondrocytes. Biochem Biophys Res Commun 1993;196:1133-1142.
56. Westermarck J, Hakkinen L, Fiers W, Kahari VM: TNF-R55-specific form of human tumor necrosis fac-tor-a induces collagenase gene expression by human skin fibroblasts. J Invest Dermatol 1995; 105:197-202.
57. Warzocha K, Salles G: The tumor necrosis factor signaling complex: Choosing a pathway toward cell death or cell proliferation. Leukemia Lymphoma 1998;29:81-92.
58. Larrick JW, Wright SC: Cytotoxic mechanism of tumor necrosis fac-tor-a. FASEB J 1990;4:3215-3223.
59. Luck MR: The gonadal extracellular matrix. Oxf Rev Reprod Biol 1994; 16:34-85.
60. Eyre DR, Paz MA, Gallop PM: Cross-linking in collagen and elas-tin. Annu Rev Biochem 1984;53: 717-748.
61. Kuhn K: Basement membrane (type IV) collagen. Matrix Biol 1994; 14: 439-445.
62. Harper E: Collagenases. Annu Rev Biochem 1980:49:1063-1078.
63. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993; 4:197-250.
64. Murdoch WJ, McCormick RJ: Enhanced degradation of collagen in apical vs. basal wall of ovulatory ovine follicle. Am J Physiol 1992; 263:E221-E225.
65. Talbot P, Martin GG, Ashby H: Formation of the rupture site in preovulatory hamster and mouse follicles: Loss of surface epithelium. Gamete Res 1987;17:287-302.
66. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995;7:728-735.
67. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-160.
68. Reich R, Daphna-Ilken D, Chun SY, Popliker M, Slager R, Adel-mann-Grill BC, Tsafriri A: Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: Role of eicosanoids. Endocrinology 1991; 129:1869-1875.
69. Tadakuma H, Okamura H, Kitaoka M, Iyama K, Usuku G: Association of immunolocalization of matrix metalloproteinase 1 with ovulation in hCG-treated rabbit ovary. J Re-prod Fertil 1993;98:503-508.
70. Mclntush EW, Pletz JD, Smith GW, Long DK, Sawyer HR, Smith MF: Immunolocalization of tissue inhibitor of metalloproteinases-1 within ovine periovulatory follicular and luteal tissues. Biol Reprod 1996;54: 871-878.
71. Columbano A: Cell death: Difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 1995;58:181-190.
72. Haanen C, Vermes I: Apoptosis and inflammation. Mediat Inflam 1995; 4:5-15.
73. Majno G, Joris I: Apoptosis, oncosis, and necrosis. Am J Pathol 1995; 146:3-15.
74. Allen RT, Hunter WJ, Agrawal DK: Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Meth 1997;37:215-228.
75. Cummings MC, Winterford CM, Walker NI: Apoptosis. Am J Surg Pathol 1997;21:88-101.
76. Murdoch WJ, Cavender JL: Effect of indomethacin on the vascular architecture of preovulatory ovine follicles: Possible implication in the luteinized unruptured follicle syndrome. Fertil Steril 1989;51:153-155.
77. Murdoch WJ, Wilken C, Young DA: Sequence of apoptosis and inflammatory necrosis within the formative ovulatory site of sheep follicles. J Reprod Fertil 1999;117:325-329.
78. Murdoch WJ, Nix KJ, Dunn TG: Dynamics of ovarian blood supply to periovulatory follicles of the ewe. Biol Reprod 1983;28:1001-1006.
79. Saikumar P, Dong Z, Weinberg JM, Venkatachalam MA: Mechanisms of cell death in hypoxia/reoxygena-tion injury. Oncogene 1998; 17: 3341-3349.
80. 2a in ovine follicles. J Anim Sci 1981;53:192-205.
81. Murdoch WJ, Slaughter RG, Ji TH: In situ hybridization analysis of ovarian prostaglandin endoperoxide synthase mRNA throughout the periovulatory period of the ewe. Domest Anim Endocrinol 1991;8: 457-459.
82. Murdoch WJ, Hansen TR, McPherson LA: Role of eicosanoids in vertebrate ovulation. Prostaglandins 1993;46:85-115.
83. Murdoch WJ, Myers DA: Effect of treatment of estrous ewes with indo-methacin on the distribution of ovarian blood to the periovulatory follicle. Biol Reprod 1983;29:1229-1232.
84. Murdoch WJ, McCormick RJ: Dose-dependent effects of indo-methacin on ovulation in the sheep: Relationship to follicular prostaglandin production, steroidogenesis, collagenolysis and leukocyte chemo-taxis. Biol Reprod 1991;45:907-911.
85. Murdoch WJ: Differential effects of indomethacin on the sheep ovary: Prostaglandin biosynthesis, intracellular calcium, apoptosis, and ovulation. Prostaglandins 1996; 52:497-506.
86. Abramson SB, Weissmann G: The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthrit Rheum 1989;32:1-9.
87. Brannstrom M, Bonello N, Wang LJ, Norman RJ: Effects of tumor necrosis factor a (TNF-a) on ovulation in the rat ovary. Reprod Fertil Dev 1995;7:67-73.
88. Suffys F, Beyaert R, Van Roy F, Fiers W: Reduced tumor necrosis factor-induced cytotoxicity by inhibition of arachidonic acid metabolism. Biochem Biophys Res Com-mun 1987;149:735-743.
89. Biswas NM, SenGupta R, Chowd-hury GR, Chattopadhyay A, Ghosh S, Chatterjee AK: Indomethacin protection against testicular lipid peroxidation and depletion of testicular ascorbic acid and serum testosterone in cadmium-treated male rats. Med Sci Res 1998;26:187-189.
90. Zhu GH, Yang KC, Lai KC, Ching CK, Wong BCY, Yeun ST, Ho J, Lam SK: Nonsteroidal antiinflammatory drugs reverse Helicobacter pylori-induced apoptosis and proliferation in gastric epithelial cells. Digest Dis Sci 1998;43:1957-1963.
91. Bast RC: Perspectives on the future of cancer markers. Clin Chem 1993; 39:2444-2451.
92. Hamilton TC: Ovarian cancer, biology. Curr Probl Cancer 1992; 16:557.
93. Talermann A: Ovarian pathology. Curr Opin Obstet Gynecol 1992;4: 608-615.
94. Collins AR: Oxidative DNA damage, antioxidants, and cancer. Bioessays 1999; 21:238-246.
95. Shukovski L, Tsafriri A: The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 1994;135:2287-2290.
96. Yamauchi J, Miyazaki T, Iwasaki S, Kishi I, Kuroshima M, Tei C, Yo-shimura Y: Effects of nitric oxide on ovulation and ovarian steroidogenesis and prostaglandin production in the rabbit. Endocrinology 1997; 138: 3630-3637.
97. Jablonka-Shariff A, Olson LM: The role of nitric oxide in oocyte meiotic maturation and ovulation: Meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 1998;139: 2944-2954.
98. Fathalla MF: Incessant ovulation-a factor in ovarian neoplasia? Lancet 1971;Vol ii: 163.
99. Fredrickson TN: Ovarian tumors of the hen. Environ Health Perspect 1987;73:35-51.
100. Balasch J, Barri PN: Follicular stimulation and ovarian cancer? Human Reprod 1993;8:990-996.
101. Spirtas R, Kaufmam, SC, Alexander NJ: Fertility drugs and ovarian cancer: Red alert or red herring? Fertil Steril 1993;59:291-293.
102. Shoham Z: Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: Where are we today? Fertil Steril 1994;62: 433-448.
103. Scott JS: How to induce ovarian cancer: And how not to. Br Med J 1984;289:781-782.
104. Mant JWF, Vessey MP: Ovarian and endometrial cancers. Cancer Surv 1994;19:287-307.
105. Tarlatzis BC, Grimbizis G, Bontis J, Mantalenakis S: Ovarian stimulation and ovarian tumours: A critical reappraisal. Hum Reprod Update 1995;1:284-301.
106. Glud E, Kjaer SK, Troisi R, Brin-ton LA: Fertility drugs and ovarian cancer. Epidemiol Rev 1998;20: 237-257.
107. Cramer DW, Welch WR: Determinants of ovarian cancer risk. II. Inference regarding pathogenesis. J Natl Cancer Inst 1983;71:717-721.
108. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH: Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 1995;92:1322-1326.
109. Rao BR, Slotman BJ: Endocrine factors in common epithelial ovarian cancer. Endocr Rev 1991; 12: 14-26.
110. Godwin AK, Perez RP, Johnson SW, Hamaguchi K, Hamilton TC: Growth regulation of ovarian cancer. Hematol Oncol Clin N Am 1992;6:829-841.
111. Mandai M, Konishi I, Kuroda H, Fukumoto M, Komatsu T, Yamamoto S, Nanbu K, Rao CV, Mori T: Messenger ribonucleic acid expression of LH/hCG receptor gene in human ovarian carcinomas. Eur J Cancer 1997;9:1501-1507.
112. Rodriguez C, Calle EE, Coates RJ, Miracle-McMahil HL, Thun MJ, Heath CW: Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995; 141:828-835.
113. Gleeson NC, Hill BJ, Moscinski LC, Mark JE, Roberts WS, Hoffman MS, Fiorica JV, Cavanagh D: Urokinase plasminogen activator in ovarian cancer. Eur J Gynaecol Oncol 1996;17:110-113.
114. Andreasen PA, Kjoller L, Christensen L, Duffy MJ: The urokinase-type plasminogen activator system in cancer metastasis. Int J Cancer 1997;72:1-22.
115. Meyer T, Hart IR: Mechanisms of tumour metastasis. Eur J Cancer 1998; 34:214-221.
116. Rabbani SA, Xing RHM: Role of urokinase and its receptor in invasion and metastasis of hormone-dependent malignancies. Int J Oncol 1998;12:911-920.
117. Berchuck A, Kohler MF, Boente MP, Rodriguez GC, Whitaker RS, Bast RC: Growth regulation and transformation of ovarian epithelium. Cancer 1993;71:545-551.
118. Kost ER, Herzog TJ, Adler LM, Williams S, Mutch DG: The role of tumor necrosis factor receptors in tumor necrosis factor-a-mediated cytolysis of ovarian cancer cell lines. Am J Obstet Gynecol 1996; 174:145-153.
119. Lindahl T, Satoh MS, Poirier GG, Klungland A: Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trend Biochem Sci 1995;20:405-411.
120. Kaufmann WK, Paules RS: DNA damage and cell cycle checkpoints. FASEB J 1996; 10:238-247.
121. Satoh MS, Lindahl T: Role of po-ly(ADP-ribose) formation in DNA repair. Nature 1992;356:356-358.
122. Nosseri C, Coppola S, Ghibelli L: Possible involvement of po-ly(ADP-ribose) polymerase in triggering stress-induced apoptosis. Exp Cell Res 1994;212:367-373.
123. Ghahremani M, Foghi A, Dorring-ton JH: Etiology of ovarian cancer: A proposed mechanism. Med Hy-poth 1999;52:23-26.
124. Ashkenazi A, Dixit VM: Death receptors: Signaling and modulation. Science 1998;281:1305-1308.
125. Martin GG, Talbot P: The role of follicular smooth muscle cells in hamster ovulation. J Exp Zool 1981;216:469-482.